<?xml version='1.0' encoding='utf-8'?>
<document id="7640156"><sentence text="Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine."><entity charOffset="0-14" id="DDI-PubMed.7640156.s1.e0" text="Sulphasalazine" /><entity charOffset="29-39" id="DDI-PubMed.7640156.s1.e1" text="thiopurine" /><entity charOffset="99-115" id="DDI-PubMed.7640156.s1.e2" text="6-mercaptopurine" /><entity charOffset="120-132" id="DDI-PubMed.7640156.s1.e3" text="azathioprine" /><pair ddi="false" e1="DDI-PubMed.7640156.s1.e0" e2="DDI-PubMed.7640156.s1.e0" /><pair ddi="false" e1="DDI-PubMed.7640156.s1.e0" e2="DDI-PubMed.7640156.s1.e1" /><pair ddi="false" e1="DDI-PubMed.7640156.s1.e0" e2="DDI-PubMed.7640156.s1.e2" /><pair ddi="false" e1="DDI-PubMed.7640156.s1.e0" e2="DDI-PubMed.7640156.s1.e3" /><pair ddi="false" e1="DDI-PubMed.7640156.s1.e1" e2="DDI-PubMed.7640156.s1.e1" /><pair ddi="false" e1="DDI-PubMed.7640156.s1.e1" e2="DDI-PubMed.7640156.s1.e2" /><pair ddi="false" e1="DDI-PubMed.7640156.s1.e1" e2="DDI-PubMed.7640156.s1.e3" /><pair ddi="false" e1="DDI-PubMed.7640156.s1.e2" e2="DDI-PubMed.7640156.s1.e2" /><pair ddi="false" e1="DDI-PubMed.7640156.s1.e2" e2="DDI-PubMed.7640156.s1.e3" /></sentence><sentence text="Thiopurine drugs are used in the treatment of inflammatory bowel disease--as are sulphasalazine and its metabolite 5-aminosalicylic acid (ASA)"><entity charOffset="0-10" id="DDI-PubMed.7640156.s2.e0" text="Thiopurine" /><entity charOffset="81-95" id="DDI-PubMed.7640156.s2.e1" text="sulphasalazine" /><entity charOffset="115-136" id="DDI-PubMed.7640156.s2.e2" text="5-aminosalicylic acid" /><entity charOffset="138-141" id="DDI-PubMed.7640156.s2.e3" text="ASA" /><pair ddi="false" e1="DDI-PubMed.7640156.s2.e0" e2="DDI-PubMed.7640156.s2.e0" /><pair ddi="false" e1="DDI-PubMed.7640156.s2.e0" e2="DDI-PubMed.7640156.s2.e1" /><pair ddi="false" e1="DDI-PubMed.7640156.s2.e0" e2="DDI-PubMed.7640156.s2.e2" /><pair ddi="false" e1="DDI-PubMed.7640156.s2.e0" e2="DDI-PubMed.7640156.s2.e3" /><pair ddi="false" e1="DDI-PubMed.7640156.s2.e1" e2="DDI-PubMed.7640156.s2.e1" /><pair ddi="false" e1="DDI-PubMed.7640156.s2.e1" e2="DDI-PubMed.7640156.s2.e2" /><pair ddi="false" e1="DDI-PubMed.7640156.s2.e1" e2="DDI-PubMed.7640156.s2.e3" /><pair ddi="false" e1="DDI-PubMed.7640156.s2.e2" e2="DDI-PubMed.7640156.s2.e2" /><pair ddi="false" e1="DDI-PubMed.7640156.s2.e2" e2="DDI-PubMed.7640156.s2.e3" /></sentence><sentence text=" S-Methylation catalyzed by thiopurine methyltransferase (TPMT) is a major pathway in the metabolism of thiopurines"><entity charOffset="28-38" id="DDI-PubMed.7640156.s3.e0" text="thiopurine" /><entity charOffset="104-115" id="DDI-PubMed.7640156.s3.e1" text="thiopurines" /><pair ddi="false" e1="DDI-PubMed.7640156.s3.e0" e2="DDI-PubMed.7640156.s3.e0" /><pair ddi="false" e1="DDI-PubMed.7640156.s3.e0" e2="DDI-PubMed.7640156.s3.e1" /></sentence><sentence text=" The hypothesis was tested that TPMT might be inhibited by sulphasalazine or isomers of ASA"><entity charOffset="59-73" id="DDI-PubMed.7640156.s4.e0" text="sulphasalazine" /><entity charOffset="88-91" id="DDI-PubMed.7640156.s4.e1" text="ASA" /><pair ddi="false" e1="DDI-PubMed.7640156.s4.e0" e2="DDI-PubMed.7640156.s4.e0" /><pair ddi="false" e1="DDI-PubMed.7640156.s4.e0" e2="DDI-PubMed.7640156.s4.e1" /></sentence><sentence text=" Sulphasalazine as well as 3-, 4- and 5-ASA inhibited recombinant human TPMT, with IC50 values of 78, 99, 2600 and 1240 microM, respectively"><entity charOffset="1-15" id="DDI-PubMed.7640156.s5.e0" text="Sulphasalazine" /><entity charOffset="40-53" id="DDI-PubMed.7640156.s5.e1" text="ASA" /><pair ddi="false" e1="DDI-PubMed.7640156.s5.e0" e2="DDI-PubMed.7640156.s5.e0" /><pair ddi="false" e1="DDI-PubMed.7640156.s5.e0" e2="DDI-PubMed.7640156.s5.e1" /></sentence><sentence text=" Kinetic studies demonstrated that the inhibition of TPMT by sulphasalazine and ASA isomers was non-competitive with regard to the thiopurine substrate, 6-MP, and was uncompetitive with regard to the methyl donor for the reaction, S-adenosyl-L-methionine"><entity charOffset="61-75" id="DDI-PubMed.7640156.s6.e0" text="sulphasalazine" /><entity charOffset="80-83" id="DDI-PubMed.7640156.s6.e1" text="ASA" /><entity charOffset="131-141" id="DDI-PubMed.7640156.s6.e2" text="thiopurine" /><entity charOffset="153-157" id="DDI-PubMed.7640156.s6.e3" text="6-MP" /><entity charOffset="200-206" id="DDI-PubMed.7640156.s6.e4" text="methyl" /><entity charOffset="231-254" id="DDI-PubMed.7640156.s6.e5" text="S-adenosyl-L-methionine" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e0" e2="DDI-PubMed.7640156.s6.e0" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e0" e2="DDI-PubMed.7640156.s6.e1" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e0" e2="DDI-PubMed.7640156.s6.e2" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e0" e2="DDI-PubMed.7640156.s6.e3" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e0" e2="DDI-PubMed.7640156.s6.e4" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e0" e2="DDI-PubMed.7640156.s6.e5" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e1" e2="DDI-PubMed.7640156.s6.e1" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e1" e2="DDI-PubMed.7640156.s6.e2" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e1" e2="DDI-PubMed.7640156.s6.e3" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e1" e2="DDI-PubMed.7640156.s6.e4" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e1" e2="DDI-PubMed.7640156.s6.e5" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e2" e2="DDI-PubMed.7640156.s6.e2" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e2" e2="DDI-PubMed.7640156.s6.e3" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e2" e2="DDI-PubMed.7640156.s6.e4" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e2" e2="DDI-PubMed.7640156.s6.e5" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e3" e2="DDI-PubMed.7640156.s6.e3" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e3" e2="DDI-PubMed.7640156.s6.e4" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e3" e2="DDI-PubMed.7640156.s6.e5" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e4" e2="DDI-PubMed.7640156.s6.e4" /><pair ddi="false" e1="DDI-PubMed.7640156.s6.e4" e2="DDI-PubMed.7640156.s6.e5" /></sentence><sentence text=" Our observations raise the possibility of a clinically significant drug-drug interaction in patients treated simultaneously with sulphasalazine and thiopurine drugs"><entity charOffset="130-144" id="DDI-PubMed.7640156.s7.e0" text="sulphasalazine" /><entity charOffset="149-159" id="DDI-PubMed.7640156.s7.e1" text="thiopurine" /><pair ddi="false" e1="DDI-PubMed.7640156.s7.e0" e2="DDI-PubMed.7640156.s7.e0" /><pair ddi="false" e1="DDI-PubMed.7640156.s7.e0" e2="DDI-PubMed.7640156.s7.e1" /></sentence><sentence text="" /></document>